I-Mab Reports Encouraging Phase 1b Data for Givastomig in Combination with Nivolumab and mFOLFOX6 at ESMO GI 2025, Confirming 83% Objective Response Rate in Gastric Cancer Patients ...

Tehran war fears are rising fast as Israel launches its most intense attacks on Iran in decades, forcing thousands to flee the capital. With over 224 Iranians killed, including civilians, and ...

We take a deep dive into the inner workings of the wildly popular AI chatbot, ChatGPT. If you want to know how its generative AI magic happens, read on.